Clinical in vitro diagnostics (IVD) are tests that can detect illnesses, infections, and diseases. These tests are done usually done in test tubes or other small platforms. While IVD can be done in a healthcare setting, some can be done at home.
Since the initial COVID-19 outbreak, the SARS-CoV-2 virus has mutated, resulting in a range of variants. SARS-CoV-2 variants of concern, exemplified most recently with Omicron, need to be de...
Targeted NGS has been instrumental in helping the healthcare community deliver on the promise of precision medicine. The Ion Torrent Genexus Integrated Sequencer has enabled targeted genomic...
Date: March 16, 2022 Time: 07:00am (PDT), 10:00am (EDT), 4:00pm (CEDT) During this webinar, we will provide an overview of the current landscape of sepsis management and the impact of rapid...
Date: February 23, 2022 Time: 09:00am (PST), 12:00pm (EST) During this webinar we will present the Lahey four-year journey of using the MBT Sepsityper® solution for the rapid identificat...
Date: October 5, 2021 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) Dr. Markus Kostrzewa shall elaborate the progress that has been made in the Research & Development department of Bru...
Date: September 27, 2021 Time: 3:00am (PDT), 6:00am (EDT), 12pm (CET) Experts are predicting an increase in influenza cases and a constant presence of SARS-CoV-2 in the shortly approaching i...
Date: September 15, 2021 Time: 9:00am (PDT), 12:00pm (EDT) Dr. Markus Kostrzewa will elaborate on the progress that has been made in Bruker Microbiology & Diagnostics, specifically on th...
Date: July 29, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Experts are predicting an increase in influenza cases and a constant presence of SARS-CoV-2 in the shortly approaching influenza season....
Date: May 20, 2021 Time: 6:00am (PDT), 9:00am (EDT), 2:00pm (BST) In this webinar, Dr Rachel Marrington, Deputy Director, and Finlay MacKenzie, Director, at Birmingham Quality UK NEQAS, will...
Thermo Fisher Scientific have spearheaded the development and democratization of next-generation sequencing, a technology that has fueled research in precision oncology and will play a key p...
Thermo Fisher Scientific have spearheaded the development and democratization of next-generation sequencing, a technology that has fueled research in precision oncology and will play a key p...
Date: December 16, 2020 Time: 7:00am (PST), 10:00am (EST) During this webinar we will discuss the implementation and impact of the MALDI Biotyper® and the MBT Sepsityper® in the clinical mi...
The COVID-19 pandemic continues to have a grip on worldwide health and global economics. Advancing molecular diagnostics is central to the diagnosis and prevention efforts surrounding the de...
Date: November 17, 2020 Time: 5:00am (PST), 8:00am (EST), 2:00pm (CET) Septicemia is a serious clinical condition with roundabout 123,000 cases of sepsis a year in England. In recent years t...
The nuclear proliferation biomarker Ki-67 has multiple potential roles in breast and other cancers, both as a prognostic but also predictive marker. However, several studies have shown that...
DATE: October 28, 2020 TIME: 6:00am PST Tumorigenesis and cancer progression are affected by the tumor immune microenvironment (TIME). The TIME not only influences the efficiency of existing...
DATE: October 27th, 2020 TIME: 6:00am PT Bruker proudly introduces the latest member of the MALDI Biotyper® product family, the MALDI Biotyper sirius one. Bruker‘s newest sirius sy...
Date: October 13, 2020 Time: 5:00am (PDT), 8:00am (EDT) Dr. Markus Kostrzewa shall ellaborate the progress that has been made in Bruker Microbiology Research and Development, including new p...
Richard Hughes: New immunogenicity strategies to meet the needs of a developing pandemic Shortly after the COVID-19 pandemic began, the subject of serological testing for anti-viral antibodi...
Learn about how the new Ion Torrent Genexus System is addressing key challenges to next-generation sequencing (NGS) implementation, like hands-on time, time-to-result, user expertise, and af...
DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
Background and aim: Multiplexing of biomarker panels by microsphere-based technologies are robust and cost-effective methods. The QuantiGene™ Plex Assay (ThermoFisher Scientific) platf...
Since the initial COVID-19 outbreak, the SARS-CoV-2 virus has mutated, resulting in a range of variants. SARS-CoV-2 variants of concern, exemplified most recently with Omicron, need to be de...
Targeted NGS has been instrumental in helping the healthcare community deliver on the promise of precision medicine. The Ion Torrent Genexus Integrated Sequencer has enabled targeted genomic...
Date: March 16, 2022 Time: 07:00am (PDT), 10:00am (EDT), 4:00pm (CEDT) During this webinar, we will provide an overview of the current landscape of sepsis management and the impact of rapid...
Date: February 23, 2022 Time: 09:00am (PST), 12:00pm (EST) During this webinar we will present the Lahey four-year journey of using the MBT Sepsityper® solution for the rapid identificat...
Date: October 5, 2021 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) Dr. Markus Kostrzewa shall elaborate the progress that has been made in the Research & Development department of Bru...
Date: September 27, 2021 Time: 3:00am (PDT), 6:00am (EDT), 12pm (CET) Experts are predicting an increase in influenza cases and a constant presence of SARS-CoV-2 in the shortly approaching i...
Date: September 15, 2021 Time: 9:00am (PDT), 12:00pm (EDT) Dr. Markus Kostrzewa will elaborate on the progress that has been made in Bruker Microbiology & Diagnostics, specifically on th...
Date: July 29, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Experts are predicting an increase in influenza cases and a constant presence of SARS-CoV-2 in the shortly approaching influenza season....
Date: May 20, 2021 Time: 6:00am (PDT), 9:00am (EDT), 2:00pm (BST) In this webinar, Dr Rachel Marrington, Deputy Director, and Finlay MacKenzie, Director, at Birmingham Quality UK NEQAS, will...
Thermo Fisher Scientific have spearheaded the development and democratization of next-generation sequencing, a technology that has fueled research in precision oncology and will play a key p...
Thermo Fisher Scientific have spearheaded the development and democratization of next-generation sequencing, a technology that has fueled research in precision oncology and will play a key p...
Date: December 16, 2020 Time: 7:00am (PST), 10:00am (EST) During this webinar we will discuss the implementation and impact of the MALDI Biotyper® and the MBT Sepsityper® in the clinical mi...
The COVID-19 pandemic continues to have a grip on worldwide health and global economics. Advancing molecular diagnostics is central to the diagnosis and prevention efforts surrounding the de...
Date: November 17, 2020 Time: 5:00am (PST), 8:00am (EST), 2:00pm (CET) Septicemia is a serious clinical condition with roundabout 123,000 cases of sepsis a year in England. In recent years t...
The nuclear proliferation biomarker Ki-67 has multiple potential roles in breast and other cancers, both as a prognostic but also predictive marker. However, several studies have shown that...
DATE: October 28, 2020 TIME: 6:00am PST Tumorigenesis and cancer progression are affected by the tumor immune microenvironment (TIME). The TIME not only influences the efficiency of existing...
DATE: October 27th, 2020 TIME: 6:00am PT Bruker proudly introduces the latest member of the MALDI Biotyper® product family, the MALDI Biotyper sirius one. Bruker‘s newest sirius sy...
Date: October 13, 2020 Time: 5:00am (PDT), 8:00am (EDT) Dr. Markus Kostrzewa shall ellaborate the progress that has been made in Bruker Microbiology Research and Development, including new p...
Richard Hughes: New immunogenicity strategies to meet the needs of a developing pandemic Shortly after the COVID-19 pandemic began, the subject of serological testing for anti-viral antibodi...
Learn about how the new Ion Torrent Genexus System is addressing key challenges to next-generation sequencing (NGS) implementation, like hands-on time, time-to-result, user expertise, and af...
DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
Background and aim: Multiplexing of biomarker panels by microsphere-based technologies are robust and cost-effective methods. The QuantiGene™ Plex Assay (ThermoFisher Scientific) platf...